Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Sep 5:12:27.
doi: 10.1186/1472-6874-12-27.

Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial)

Eva R Groenewoud  1 , Nick S Macklon, Ben J Cohlen; ANTARCTICA trial study group
Affiliations
Randomized Controlled Trial

Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial)

Eva R Groenewoud et al. BMC Womens Health. .

Abstract

Background: Frozen thawed embryo transfer (FET) is a cost-effective adjunct to IVF or IVF-ICSI treatment. In order to optimize treatment outcome, FET should be carried out during a period of optimal endometrial receptivity. To optimize implantation several methods for endometrium preparation have been proposed. In natural cycle FET (NC-FET), the endometrium develops under endogenous hormonal stimulation. The development of the dominant follicle and endometrium is monitored by ultrasound and FET is timed after triggering ovulation induction or determination of the spontaneous LH surge. In an artificial cycle FET (AC-FET) estrogens and progesterone are administered to prepare the endometrium for implantation. While the currently available data show no significant difference in pregnancy rates between these methods, well designed randomized controlled trials are lacking. Moreover there is little literature on difference in cancellation rates, cost-efficiency and adverse events.

Methods and design: In this randomized, multi-centre, non-inferiority trial we aim to test the hypothesis that there is no significant difference in live birth rates between patients undergoing NC-FET versus AC-FET. The primary outcome will be live birth rate per embryo transfer procedure. Secondary outcomes will be ongoing and clinical pregnancy rate, cancellation rate, (serious) adverse events and cost-efficiency. Based on a live birth rate of 20% and a minimal clinical important difference of 7.5% (one-sided alpha 2.5%, beta 20%) a total of 1150 patients will be needed. Analyzes will be performed using both per protocol as well as intention to treat analyses.

Discussion: This prospective, randomized, non-inferiority trial aims to address the hypothesis that there is no significant difference in live birth rates between patients undergoing NC-FET versus patients undergoing AC-FET. Moreover it addresses cost-efficiency as well as the perceived burden of both treatments.

Trial register: Netherlands trial register (NTR): 1586.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart eligible patients.
Figure 2
Figure 2
Flowchart natural cycle.
Figure 3
Figure 3
Flowchart artificial cycle.
See this image and copyright information in PMC

References

    1. Aflatoonian A, Mansoori MF, Mashayekhy M, Mohamadian F. Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles. J Assist Reprod Genet. 2010;27:695–700. doi: 10.1007/s10815-010-9470-z. - DOI - PMC - PubMed
    1. Belva F, Henriet S, Van den Abbeel E, Camus M, Devroey P, Van der Elst J. et al.Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod. 2008;23:2227–2238. doi: 10.1093/humrep/den254. - DOI - PubMed
    1. Li HZ, Qiao J, Chi HB, Chen XN, Liu P, Ma CH. Comparison of the major malformation rate of children conceived from cryopreserved embryos and fresh embryos. Chin Med J (Engl) 2010;123:1893–1897. - PubMed
    1. Edwards RG. Human uterine endocrinology and the implantation window. Ann N Y Acad Sci. 1988;541:445–454. doi: 10.1111/j.1749-6632.1988.tb22281.x. - DOI - PubMed
    1. Yoshinaga K. Uterine receptivity for blastocyst implantation. Ann N Y Acad Sci. 1988;541:424–431. doi: 10.1111/j.1749-6632.1988.tb22279.x. - DOI - PubMed

Publication types

MeSH terms